Group 1 - The core viewpoint of the article highlights the performance of the Huatai-PineBridge Medical Active Growth One-Year Holding Mixed Fund A, which has a latest net value of 0.7909 yuan, reflecting a decline of 1.25% [1] - The fund has shown a one-month return of 14.91%, ranking 312 out of 4699 in its category; a six-month return of 60.28%, ranking 58 out of 4543; and a year-to-date return of 61.47%, ranking 78 out of 4501 [1] - The fund's top ten stock holdings account for a total of 61.79%, with significant positions in companies such as Sangfor Technologies (10.07%), Innovent Biologics (8.94%), and Kelun Pharmaceutical (8.71%) [1] Group 2 - The Huatai-PineBridge Medical Active Growth One-Year Holding Mixed Fund A was established on August 21, 2020, and as of June 30, 2025, it has a total scale of 1.922 billion yuan [1] - The fund manager, Zheng Lei, has a background in social medicine and health management from Fudan University and has held various positions in the finance and investment sectors, including roles at Guotai Junan Securities and China Oceanwide Fund Management [2]
8月12日汇添富医疗积极成长一年持有混合A净值下跌1.25%,近1个月累计上涨14.91%
Sou Hu Cai Jing·2025-08-12 11:51